News | Cardiovascular Ultrasound | May 10, 2022

Butterfly Network Recognized As “Best New Ultrasound Solution” in 2022 MedTech Breakthrough Awards Program

Prestigious annual awards program honors outstanding health and medical technology products and companies

MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global health and medical technology market, today announced that Butterfly Network, Inc., a digital health company transforming care with handheld, whole-body ultrasound, has been selected as the winner of the “Best New Ultrasound Solution” award in the sixth annual MedTech Breakthrough Awards program.

May 10, 2022 — MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global health and medical technology market, today announced that Butterfly Network, Inc., a digital health company transforming care with handheld, whole-body ultrasound, has been selected as the winner of the “Best New Ultrasound Solution” award in the sixth annual MedTech Breakthrough Awards program.

Butterfly's groundbreaking ultrasound solution, Butterfly iQ+, is the world’s only ultrasound transducer that can perform whole-body imaging in a single, handheld probe. Powered by Ultrasound-on-Chip technology, Butterfly enables the acquisition of imaging information from an affordable, powerful device that fits in a healthcare professional’s pocket with a unique combination of cloud-connected software, professional services, and hardware technology that is easily accessed through a mobile app.

Fusing semiconductors, artificial intelligence, and cloud technology, Butterfly iQ+ is designed to enable the practical application of ultrasound information into the clinical workflow. Once connected to a compatible iOS or Android device, users can select from six imaging modes and 20+ presets with the swipe of a finger before scanning. The device’s Needle Viz™ and unique dual-imaging mode helps with accuracy and control when performing intricate in-plane procedures such as vascular access, nerve blocks and musculoskeletal injections¹. Additionally, its patented on-chip digital micro-beamforming enables 15 percent faster frame rates and 60 percent faster pulse repetition frequency².

“We are honored to be recognized by MedTech Breakthrough for our Butterfly iQ+ innovation,” said Dr. Todd Fruchterman, President and CEO of Butterfly Network. “Butterfly’s transformational role of bringing ultrasound information into the clinical workflow in a practical way continues to gain traction and is increasingly enabling more informed care decisions across the healthcare ecosystem. Our team is committed to bringing Butterfly to the pockets of clinicians everywhere, so in time it can become an advanced clinical assessment tool that is as ubiquitous as the stethoscope.”

The mission of the MedTech Breakthrough Awards is to honor excellence and recognize the innovation, hard work and success in a range of health and medical technology categories, including Telehealth, Clinical Administration, Patient Engagement, Electronic Health Records (EHR), Virtual Care, Medical Devices, Medical Data and many more. This year’s program attracted more than 3,900 nominations from over 15 different countries throughout the world.

“Research³ has shown that the use of point of care imaging in primary care settings results in a change in diagnosis and a change in care management across almost half of all patients,” said James Johnson, managing director, MedTech Breakthrough. “With Butterfly, clinicians aim to address this issue head-on with greater insights to aid in early detection and diagnosis—ultimately accelerating and improving treatment. Having an easily accessible, easy-to-use, AI-enabled imaging tool in the pocket of every practitioner means more informed, better decisions can be made earlier in care, every time. Congratulations to Butterfly Network for being our choice for ‘Best New Ultrasound Solution’ and ushering in a new era of healthcare with scalable, affordable point-of-care ultrasound.”

Additionally, Butterfly Blueprint is Butterfly Network’s system-wide platform designed to support the scaled deployment of ultrasound across hospitals and health systems. Butterfly Blueprint is complemented with optional services including Caption Health’s AI-guided software, which empowers healthcare professionals without sonography expertise to capture and interpret cardiac ultrasound images for earlier disease detection and better patient management. Butterfly Blueprint’s device-agnostic software integrates with non-Butterfly devices, as well as with other clinical and administrative systems including the PACS and EMR.

For more information: https://www.butterflynetwork.com

References:

¹Not all Butterfly iQ+ features are available in all countries.
²Compared to Butterfly’s first generation iQ. For more information, please visit: https://www.butterflynetwork.com/iq
³Aakjær Andersen C, Brodersen J, Davidsen AS, et al Use and impact of point-of-care ultrasonography in general practice: a prospective observational study. BMJ Open 2020;10:e037664.


Related Content

Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Here is a recap of what DAIC viewers found most interesting during the month of January: 1. A Dietary Supplement Leads ...

Home February 01, 2023
Home
News | Cardiovascular Business

January 24, 2023 — Cardiothoracic surgeon Thomas E. MacGillivray, MD, from MedStar Health, was elected President of The ...

Home January 24, 2023
Home
News | Cardiovascular Business

January 19, 2023 — The volunteers and staff of the American Heart Association and the American Stroke Association are ...

Home January 19, 2023
Home
News | Cardiovascular Business

January 19, 2023 — Shockwave Medical, Inc., a pioneer in the development of Intravascular Lithotripsy (IVL) to treat ...

Home January 19, 2023
Home
News | Cardiovascular Business

January 11, 2023 — The Alameda, Calif.-based global healthcare company Penumbra has announced U.S. Food & Drug ...

Home January 11, 2023
Home
News | Cardiovascular Business

January 9, 2023 — CinCor Pharma, Inc. announced that it has entered into a definitive agreement with AstraZeneca under ...

Home January 09, 2023
Home
News | Cardiovascular Business

January 9, 2023 — ReCor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd. announced the appointment ...

Home January 09, 2023
Home
News | Cardiovascular Business

January 5, 2023 — StreamlineMD has provided updates for 2023 Radiology and IR CPT coding, which may impact your practice ...

Home January 05, 2023
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

As 2022 comes to a close, the Diagnostic and Interventional Cardiology team takes a look at the year's most viewed ...

Home January 02, 2023
Home
News | Cardiovascular Business

December 27, 2022 — President Joe Biden signed into law the Cardiovascular Advances in Research and Opportunities Legacy ...

Home December 27, 2022
Home
Subscribe Now